Oncotarget How a Simple Blood Test Could Predict Colorectal Cancer Surgery Success The concentration of cell-free DNA (cfDNA) before and after surgery may be related to the... read more February 26, 2025
Oncotarget Combining Regorafenib and TAS102 to Target Gastrointestinal Cancers and Overcome Cancer Stemness In this research paper, researchers demonstrate a promising new treatment option for refractory metastatic gastrointestinal... read more August 9, 2024
Oncotarget Triple Combination Treatment Overcomes Colorectal Cancer Resistance In a new study, researchers aimed to elucidate the role of cancer stemness in the... read more December 14, 2023
Oncotarget Can the Creatine Shuttle be Targeted to Fight Colorectal Cancer? In a new study, researchers investigated the creatine shuttle pathway as a potential therapeutic target... read more May 25, 2023
Oncotarget New Study: Investigation of Colorectal Cancer-Promoting Protein In the cover paper published in Oncotarget’s Volume 12, Issue 24, researchers investigated the... read more November 24, 2021
Oncotarget The First Study on CABYR Isoforms in Colorectal Cancer Researchers evaluate CABYR isoforms a/b and c mRNA expression in colorectal cancer in hopes... read more March 3, 2021